NextPlat's ClearMetrx Subsidiary to Launch Artificial Intelligence-Powered ClearMetrX 4.0 Software for Modernized Healthcare Analytics and Reporting
NextPlat (NASDAQ: NXPL) has announced the development of ClearMetrX 4.0, an AI-enhanced healthcare data analytics and reporting software. The platform, set to be rolled out internally in Q4 2025 with commercial deployment in H1 2026, will integrate advanced AI capabilities to improve healthcare operations efficiency and patient outcomes.
The software will feature AI-powered functionalities including revenue forecasting, predictive inventory management, anomaly detection, audit assistance, fraud detection, and what-if simulations. This development aligns with the growing AI healthcare market, which is projected to reach $187.69 billion by 2030, with a CAGR of 38.62% from 2025 to 2030.
NextPlat (NASDAQ: NXPL) ha annunciato lo sviluppo di ClearMetrX 4.0, un software di analisi dati sanitari e reporting potenziato dall'IA. La piattaforma, prevista per essere implementata internamente nel Q4 2025 con una diffusione commerciale nel H1 2026, integrerà capacità AI avanzate per migliorare l'efficienza delle operazioni sanitarie e gli esiti per i pazienti.
Il software offrirà funzionalità alimentate dall'IA tra cui previsione di fatturato, gestione predittiva delle scorte, rilevamento di anomalie, assistenza agli audit, rilevazione di frodi e simulazioni what-if. Questo sviluppo è in linea con il mercato sanitario AI in crescita, che si prevede raggiungerà $187.69 miliardi entro il 2030, con un CAGR del 38,62% dal 2025 al 2030.
NextPlat (NASDAQ: NXPL) ha anunciado el desarrollo de ClearMetrX 4.0, un software de analítica de datos de salud e informes potenciado por IA. La plataforma, que se implementará internamente en Q4 2025 con despliegue comercial en H1 2026, integrará capacidades avanzadas de IA para mejorar la eficiencia de las operaciones sanitarias y los resultados de los pacientes.
El software contará con funcionalidades impulsadas por IA, como pronóstico de ingresos, gestión predictiva de inventario, detección de anomalías, asistencia en auditorías, detección de fraude y simulaciones de escenarios what-if. Este desarrollo se alinea con el creciente mercado de IA en salud, que se proyecta alcance $187.69 mil millones para 2030, con una CAGR del 38.62% de 2025 a 2030.
NextPlat (NASDAQ: NXPL)은 ClearMetrX 4.0의 개발을 발표했습니다. 이는 AI가 강화된 헬스케어 데이터 분석 및 보고 소프트웨어입니다. 이 플랫폼은 2025년 4분기에 내부적으로 롤아웃되고 2026년 상반기에 상용 배포될 예정이며, 의료 운영의 효율성과 환자 결과를 개선하기 위한 고급 AI 기능을 통합합니다.
소프트웨어는 매출 예측, 재고 관리 예측, 이상 탐지, 감사 지원, 사기 탐지 및 what-if 시뮬레이션 등 AI 기반 기능을 갖추게 될 것입니다. 이 개발은 2025년~2030년 사이 연평균 성장률(CAGR) 38.62%로 성장하는 AI 헬스케어 market과 발맞추어 2030년까지 $187.69 billion에 이를 것으로 예상됩니다.
NextPlat (NASDAQ: NXPL) a annoncé le développement de ClearMetrX 4.0, un logiciel d’analyse de données sanitaires et de reporting amélioré par l’IA. La plateforme, qui sera déployée en interne au Q4 2025 et commercialement au H1 2026, intégrera des capacités d’IA avancées pour améliorer l’efficacité des opérations de santé et les résultats des patients.
Le logiciel disposera de fonctionnalités pilotées par l’IA, notamment la prévision des revenus, la gestion prédictive des stocks, la détection d’anomalies, l’assistance lors des audits, la détection de fraudes et des simulations what-if. Ce développement s’inscrit dans le marché croissant de l’IA en santé, qui devrait atteindre $187,69 milliards d’ici 2030, avec un TCAC de 38,62% entre 2025 et 2030.
NextPlat (NASDAQ: NXPL) hat die Entwicklung von ClearMetrX 4.0 angekündigt, eine KI-gestützte Software zur Gesundheitsdatenanalyse und Berichterstattung. Die Plattform soll intern im Q4 2025 eingeführt und kommerziell in H1 2026 eingesetzt werden, sie wird fortschrittliche KI-Funktionen integrieren, um die Effizienz der Gesundheitsabläufe und die Ergebnisse für Patienten zu verbessern.
Die Software wird KI-gestützte Funktionen umfassen, darunter Umsatzprognosen, vorausschauendes Bestandsmanagement, Anomalieerkennung, Audit-Unterstützung, Betrugserkennung und What-if-Simulationen. Diese Entwicklung steht im Einklang mit dem wachsenden AI-Gesundheitsmarkt, der voraussichtlich bis 2030 auf $187,69 Milliarden anwachsen wird, mit einer CAGR von 38,62% von 2025 bis 2030.
NextPlat (NASDAQ: NXPL) أعلنت عن تطوير ClearMetrX 4.0، وهو برنامج تحليل بيانات الرعاية الصحية وتقارير معزز بالذكاء الاصطناعي. من المقرر طرح المنصة داخلياً في الربع الرابع من 2025 مع نشر تجاري في الربع الأول من 2026، وستدمج قدرات AI متقدمة لتحسين كفاءة عمليات الرعاية الصحية ونتائج المرضى.
سيحتوي البرنامج على وظائف مدعومة بالذكاء الاصطناعي بما في ذلك التنبؤ بالإيرادات، وإدارة المخزون التنبؤية، وكشف الشذوذ، ومساعدة التدقيق، وكشف الاحتيال، ومحاكاة ما-إذا. يتماشى هذا التطور مع سوق الذكاء الاصطناعي في الرعاية الصحية الذي يتوقع أن يصل إلى $187.69 مليار بحلول 2030، مع معدل نمو مركب سنوي قدره 38.62% من 2025 إلى 2030.
NextPlat (NASDAQ: NXPL) 宣布开发 ClearMetrX 4.0，这是一个由人工智能增强的医疗保健数据分析与报告软件。该平台计划在 2025年第四季度 内部推行，并在 2026年上半年 进行商业部署，将整合先进的 AI 功能以提高医疗保健运营效率和患者结局。
该软件将具备 AI 驱动的功能，包括收入预测、预测性库存管理、异常检测、审计协助、欺诈检测以及情景模拟（what-if）。这一发展与日益增长的医疗 AI 市场相吻合，预计到 2030 年将达到 $187.69 十亿美元，2025 年至 2030 年的复合年增长率（CAGR）为 38.62%。
- Entry into the rapidly growing AI healthcare market projected to reach $187.69B by 2030
- Enhanced revenue forecasting and inventory management capabilities through AI integration
- Expanded service offering with fraud detection and compliance reporting features
- Building upon existing successful ClearMetrX platform with proven market acceptance
- Delayed commercial deployment until first half of 2026
- Potential implementation and adoption challenges in healthcare settings
- Competition in the growing AI healthcare analytics market
Insights
NextPlat's ClearMetrX 4.0 leverages AI to tap into the rapidly growing healthcare AI market, potentially creating new revenue streams by 2026.
NextPlat's announcement of ClearMetrX 4.0 represents a strategic evolution of their healthcare analytics platform with artificial intelligence integration scheduled for internal deployment in Q4 2025 and commercial release in H1 2026. This development positions the company to capitalize on the healthcare AI market that's projected to grow from
The enhanced platform offers substantial operational value through AI-powered features including revenue forecasting, predictive inventory management, anomaly detection, and fraud identification. These capabilities directly address critical pain points in healthcare operations by optimizing resource allocation, improving compliance, and potentially reducing waste—all factors that contribute to both operational efficiency and improved patient outcomes.
Most importantly, this represents a dual revenue opportunity for NextPlat: first, by implementing these technologies across their own pharmacy operations to improve internal efficiency; and second, by commercializing the software to their existing client base of physicians, MSOs, 340B entities, and pharmacies. The decision to roll out internally before commercial deployment suggests confidence in the technology while allowing for real-world optimization.
For NextPlat, this development represents an evolution from being primarily a data analytics provider to offering decision support and operational intelligence—higher-value services that typically command premium pricing in healthcare technology. By focusing on revenue forecasting and inventory management, the platform addresses direct financial concerns of healthcare organizations while potentially improving patient adherence metrics, creating a compelling value proposition across both business and clinical domains.
Enhanced Software Suite to Feature AI-Assisted Analytics and Insights Designed to Support Greater Efficiency in Healthcare Operations While Driving Improved Patient Adherence and Outcomes
ClearMetrX is a cloud-based, end-to-end reporting platform that streamlines data analytics for physicians, management services organizations (MSOs), 340B entities, and pharmacies, and is actively used across the Company's pharmacies and client network. ClearMetrX 4.0 will integrate an array of AI-powered enhancements into the software, designed to increase its value as a comprehensive decision-support system, enabling a more streamlined way to collect, analyze and operationalize organizational healthcare data. According to Grandview Research, the global AI in healthcare market size was estimated at
Birute Norkute, Vice President of Healthcare Operations at NextPlat, said, "Since its introduction, ClearMetrX has demonstrated its capabilities to positively impact not only the business of healthcare for us and a growing list of customers, but importantly, support better outcomes through improved patient adherence. With ClearMetrX 4.0, we are honoring our commitment to harness the power of technology such as AI to further improve the efficiency and effectiveness of healthcare to the benefit of all stakeholders."
Highlighted features of ClearMetrX 4.0 include:
- Revenue Forecasting: Utilizing AI/ML models to predict revenue, prescription volumes, and patient demand with accuracy.
- Predictive Inventory Management: Intelligent AI forecasting to optimize stock levels and reduce shortages or waste.
- Anomaly & Exception Detection: Real-time AI tools to spot abnormal prescribing, dispensing, or claims patterns.
- Audit Assistance, Analytics & Reporting: AI-powered dashboards that automate evidence gathering, compliance reporting, and deliver actionable analytics.
- Fraud Detection: Advanced AI analytics to identify suspicious billing or dispensing activity.
- What-If Simulations: AI-driven scenario models to evaluate financial and compliance outcomes.
To learn more about ClearMetrX or to request information on how it can meet your needs or to schedule a demonstration, please visit https://www.clearmetrx.com/
For more information about NextPlat, please visit www.NextPlat.com and connect with us on Facebook, LinkedIn and X.
About NextPlat Corp
Nextplat is a global consumer products and services company providing healthcare and technology solutions through e-Commerce and retail channels worldwide. Through acquisitions, joint ventures, and collaborations, the Company seeks to assist businesses in selling their goods online, domestically, and internationally, allowing customers and partners to optimize their e-Commerce presence and revenue. NextPlat currently operates an e-Commerce communications division offering voice, data, tracking, and IoT products and services worldwide as well as pharmacy and healthcare data management services in
Forward-Looking Statements
Certain statements in this release constitute forward-looking statements. These statements include the capabilities and success of the Company's business and any of its products, services or solutions. The words "believe," "forecast," "project," "intend," "expect," "plan," "should," "would," and similar expressions and all statements, which are not historical facts, are intended to identify forward-looking statements. These forward-looking statements involve and are subject to known and unknown risks, uncertainties and other factors, including the Company's ability to launch additional e-commerce capabilities for consumer and healthcare products and its ability to grow and expand as intended, any of which could cause the Company to not achieve some or all of its goals or the Company's previously reported actual results, performance (finance or operating), including those expressed or implied by such forward-looking statements. More detailed information about the Company and the risk factors that may affect the realization of forward-looking statements is set forth in the Company's filings with the Securities and Exchange Commission (the "SEC"), copies of which may be obtained from the SEC's website at www.sec.gov. The Company assumes no, and hereby disclaims any, obligation to update the forward-looking statements contained in this press release.
Media and Investor Contact for NextPlat Corp:
Michael Glickman
MWGCO, Inc.
917-397-2272
mike@mwgco.net
View original content to download multimedia:https://www.prnewswire.com/news-releases/nextplats-clearmetrx-subsidiary-to-launch-artificial-intelligence-powered-clearmetrx-4-0-software-for-modernized-healthcare-analytics-and-reporting-302563941.html
SOURCE NextPlat Corp.
FAQ
When will NextPlat (NXPL) launch ClearMetrX 4.0?
What are the main features of NextPlat's ClearMetrX 4.0 software?
How large is the AI healthcare market that NextPlat is entering?
Who are the target customers for NextPlat's ClearMetrX 4.0?
What problems does NextPlat's ClearMetrX 4.0 solve?
